GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Machinery, Furniture, Equipment

BCAL Diagnostics (ASX:BDX) Machinery, Furniture, Equipment : A$2.09 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Machinery, Furniture, Equipment?

BCAL Diagnostics's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was A$2.09 Mil.

BCAL Diagnostics's quarterly Machinery, Furniture, Equipment increased from Dec. 2022 (A$0.16 Mil) to Jun. 2023 (A$1.20 Mil) and increased from Jun. 2023 (A$1.20 Mil) to Dec. 2023 (A$2.09 Mil).

BCAL Diagnostics's annual Machinery, Furniture, Equipment increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.19 Mil) and increased from Jun. 2022 (A$0.19 Mil) to Jun. 2023 (A$1.20 Mil).


BCAL Diagnostics Machinery, Furniture, Equipment Historical Data

The historical data trend for BCAL Diagnostics's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Machinery, Furniture, Equipment Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Machinery, Furniture, Equipment
0.19 1.20

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Machinery, Furniture, Equipment Get a 7-Day Free Trial 0.14 0.19 0.16 1.20 2.09

BCAL Diagnostics Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


BCAL Diagnostics (ASX:BDX) Business Description

Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.

BCAL Diagnostics (ASX:BDX) Headlines

From GuruFocus

Embecta Corp Investor Event Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

BD Board Declares Dividend

By PRNewswire 01-23-2024

Q2 2022 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024